Eye Tech Care SA

Chinese pharma companies are now taking some of their principal products to the smaller global markets of Southeast Asia, which a number are targeting in an expansion push. Hong Kong- and Shanghai-lis

IN VITRO DIAGNOSTICS bioTheranostics Inc. Late round brings $32mm to bioTheranostics ; company becomes independent Molecular diagnostics firm bioTheranostics Inc. raised $32mm in a late-stage f

Each year, START-UP reviews the sectors of the medical device industry that received private funding to identify investment trends and to discover what will be fueling the growth of medtech strategi